Biotechnology

New patent for ONZETRA XSAIL Currax drug – DrugPatentWatch

[ad_1]

Copyright © DrugPatentWatch. Originally published in New patent for ONZETRA XSAIL Currax drug

Annual Drug Patent Expiration for ONZETRA+XSAIL
Annual Drug Patent Expiration for ONZETRA+XSAIL

Onzetra Xsail is a drug marketed by Currax and included in one NDA. It is available from a single supplier. There are seventeen patents protecting this drug.

ONZETRA XSAIL drug price trends.

This drug has two hundred and fifty four patent family members in twenty nine countries.

The generic ingredient in ONZETRA XSAIL is sumatriptan succinate. One registered supplier for this compound. Additional details are available on Sumatriptan’s succinate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published in New patent for ONZETRA XSAIL Currax drug

[ad_2]

Source link

Related Articles

Back to top button